Safety of pembrolizumab (pem) in patients (pts) who stopped ipilimumab (ipi) due to immune-related adverse events. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract ...
Background: Total hip arthroplasty is a successful surgery, that fails at a rate of approximately 10% at ten years from surgery. Causes for failure are mainly aseptic loosening of one or both ...
Survival analysis anticipates the expected lifespans of individuals as well as the timing of other events. Learn about its pros and cons.
To determine the factors that influence component survival we followed a large number of consecutive primary total hip arthroplasties performed in the same Institute. The cohort was large enough to be ...